Sabra Health Care REIT Inc.

SBRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$19.87

+$0.13 (+0.66%)

At close: Sep 21, 2026, 4:00 PM ET

$19.80

-$0.07 (-0.34%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $4.98B

Enterprise Value $6.04B

Beta 0.64

Average Volume 2.86M

Shares Outstanding (Diluted) 252.27M

Shares Change YoY 4.71%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US78573L1061

Price Performance

Price Change 1M -2.5%

Price Change 3M 6.7%

Price Change 6M 0.1%

Price Change YTD 3.8%

Price Change 1Y 7.5%

Price Change 3Y 42.5%

Price Change 5Y 30.4%

1M CAGR (ann.) -4.2%

1Y CAGR (ann.) 12.1%

5Y CAGR (ann.) 12.3%

All-Time CAGR 7.0%

Valuation

PE Ratio 55.19

Forward PE 26.92

PEG Ratio -1.12

Forward PEG 1.19

PS Ratio 5.83

Forward PS 5.00

PB Ratio 1.82

P/FCF Ratio 11.27

P/Adj. FCF Ratio 11.69

P/OCF Ratio 13.52

EV/Sales 7.02

EV/EBIT 34.24

EV/EBITDA 16.82

EV/FCF 13.57

Earnings Yield 1.8%

FCF Yield 8.9%

Adj. FCF Yield 8.6%

Financial Health

Net Debt $1.02B

Total Debt $1.26B

Cash & Short-Term Investments $231.58M

Total Assets $5.51B

Current Ratio 43.68

Quick Ratio 43.68

Debt / Equity Ratio 0.96

Debt / EBITDA 3.50

Debt / FCF 2.82

OCF / Debt 0.37

Interest Coverage 1.15

Altman Z-Score 1.42

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 72.6%

Operating Profit Margin 19.0%

EBITDA Margin 41.8%

Net Profit Margin 7.6%

FCF Margin 51.7%

Adj. FCF Margin 49.9%

SBC / Revenue 1.5%

SBC Impact (per share) -3.6%

Returns

Return on Assets 1.2%

Return on Equity 2.3%

Return on Invested Capital 23.3%

Return on Capital Employed 1.9%

Return on Tangible Assets 1.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 16.6%

Revenue CAGR 5Y 14.1%

Revenue CAGR 10Y 12.6%

EPS CAGR 3Y 15.7%

EPS CAGR 5Y 82.8%

EPS CAGR 10Y -8.4%

FCF CAGR 3Y 12.2%

FCF CAGR 5Y 7.2%

FCF CAGR 10Y 10.5%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 29

EPS Growth Next 3Y 33.7%

Revenue Growth Next 3Y 10.9%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $9.40

Graham Upside -52.7%

Lynch Fair Value $9

Lynch Upside -54.7%

Price Target $22.57

Price Target Upside 13.6%

Cash Flow

Operating Cash Flow $469.94M

Free Cash Flow $444.78M

Adj. Free Cash Flow $428.55M

FCF Per Share $1.37

OCF Per Share $1.47

OCF/S Ratio 43.2%

Income Statement

Revenue $859.56M

Gross Profit $387.98M

Operating Income $163.61M

EBITDA $358.9M

Net Income $64.53M

EPS (Diluted) $0.36

Revenue / Employee $14.82M

Profit / Employee $1.11M

Employees 58

Dividends

Annual Dividend $1.20

Dividend Yield 6.04%

Payout Ratio 333.3%

FCF Payout Ratio 84.0%

Adj. FCF Payout Ratio 87.2%

Dividend Growth (YoY) 0.0%

Pay Frequency Quarterly

Ex-Dividend Date Aug 13, 2026